期刊文献+

3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂的构效关系研究进展 被引量:8

Progresses in researches of HMG CoA reductase inhibitors
下载PDF
导出
摘要 3-羟基-3-甲基戊二酰辅酶A(HMG CoA)还原酶抑制剂是治疗高胆固醇血症的有效药物。现综述该类药物的发展概况和作用机制,并从母环、连接链和侧链三部分总结其构效关系,为国内研发新的HMG CoA还原酶抑制剂提供参考。 3-Hydroxy-3-methylglutaryl-coenzyme A( HMG CoA) reductase inhibitors are effec- tively used in the treatment of hypercholesterolemia. This paper overviews the current status of researches of the HMG CoA reductase inhibitors including bioactive mechanism and structure-activity relationship of HMG CoA reductase inhibitors in respect of the parent skeleton, middle spacers and side chains, which may provide some clues for further development of such new inhibitors.
出处 《中国新药杂志》 CAS CSCD 北大核心 2006年第22期1907-1912,共6页 Chinese Journal of New Drugs
关键词 3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂 构效关系 降血脂药 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors structure-activity relationship hypolipidemic agent
  • 相关文献

参考文献22

  • 1STEINBERG D.Cholesterol and cardiovascular disease:current perspectives.Introduction and overview[J].Circulation,1987,76 (3):502-503.
  • 2ISTVAN ES,DEISENHOFER J.Structural mechanism for statin inhibition of HMG CoA reductase[J].Science,2001,292 (5):1160-1164.
  • 3STOKKER GE,HOFFMAN WF,ALBERTS AW,et al.3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.1.structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivatives[J].J Med Chem,1985,28 (3):347-358.
  • 4HATORI H,SATO B,SATO I,et al.FR901512,a novel HMG CoA reductase inhibitor produced by an Agonomycetous fungus No.14919.Ⅱ.Taxonomy of the producing organism,fermentation,isolation and physico-chemical properties[J].J Antibiot (Tokyo),2004,57(4):264 -270.
  • 5LEE TJ,HOLTZ WJ,SMITH RL,et al.3-Hydroxy-3-methylgluaryl-coenzyme A reductase inhibitors.8.Side chain ether analogues of lovastatin[J].J Med Chem,1991,34(8):2474 -2477.
  • 6BONE ED,DAVIDSON AH,LEWIS CN,et al.Synthesis and biological evaluation of dihydroeptastatin,a novel inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase[J].J Med Chem,1992,35(18):3388 -3393.
  • 7KATHAWALA FG.HMG CoA reductase inhibitors:an exciting development in the treatment of hyperlipoproteinemia[J].Med Res Rev,1991,11(1):121 -146.
  • 8FESTAL D,NIOCHE JY,DESCOURS D,et al.Preparation of benzopyrans and analogs as anticholesteremics and platelet aggregation inhibitors:EP,380392[P].1990-08-01.
  • 9MCTAGGART F,BUCKETT L,DAVIDSON R,et al.Preclinical and clinical pharmacology of rosuvastatin,a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor[J].Am J Cardiol,2001,87(Suppl):S28-S32.
  • 10KAJINAMI K,MABUCHI H,SAITO Y.NK-104:a novel synthetic HMG CoA reductase inhibitor[J].Expert Opin Investig Drugs,2000,9(11):2653-2661.

同被引文献89

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部